Xueshuai Wan

机构：Chinese Academy of Medical Sciences & Peking Union Medical College, Peking Union Medical College Hospital · ORCID：0000-0003-2140-5384

发表论文 80 篇 · 总被引 1757 次 · h-index 22

代表论文

• Programmed cell death in hepatocellular carcinoma: mechanisms and therapeutic prospects (2024 · Cell Death Discovery · 被引 43)
• Genetically-modified, redirected T cells target hepatitis B surface antigen-positive hepatocytes and hepatocellular carcinoma lesions in a clinical setting (2024 · Clinical and Molecular Hepatology · 被引 28)
• Clinical results of an HBV-specific T-cell receptor-T-cell therapy (SCG101) in patients with HBV-related hepatocellular carcinoma treated in an investigator-initiated, interventional trial (2025 · Gut · 被引 14)
• Combined TACE with Targeted and Immunotherapy versus TACE Alone Improves DFS in HCC with MVI: A Multicenter Propensity Score Matching Study (2025 · Journal of Hepatocellular Carcinoma · 被引 8)
• LINC02257 regulates colorectal cancer liver metastases through JNK pathway (2024 · Heliyon · 被引 7)
• Learning-based early detection of post-hepatectomy liver failure using temporal perioperative data: a nationwide multicenter retrospective study in China (2025 · EClinicalMedicine · 被引 6)